Concepedia

Author

Maria Georganaki

Uppsala University

Also Known As

Maria Georganaki

51

Publications

972

Citations

11

H-Index

15

Concepts

All Affiliations

Uppsala UniversityScience for Life LaboratoryUniversity of GothenburgUppsala University HospitalSahlgrenska University Hospital
MG

About

Maria Georganaki is an author at Uppsala University specializing in tumor biology, vascular biology, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

205

2

Cell Biology

2

2

205

3

Immunology

2

2

205

4

Cancer Cell Biology

2

2

205

5

Cell Signaling

1

1

92

Maria Georganaki

×

10

Publications

788

Citations

10

H-Index

YearCitations

VEGF suppresses T‐lymphocyte infiltration in the tumor microenvironment through inhibition of NF‐κB‐induced endothelial activation

Hua Huang, Elise Langenkamp, Maria Georganaki,

The FASEB Journal

2014

179

Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma

Luuk van Hooren, Alessandra Vaccaro, Mohanraj Ramachandran,

Nature Communications

2021

142

Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma

Mohanraj Ramachandran, Alessandra Vaccaro, Tiarne van de Walle,

Cancer Cell

2023

115

Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis

Yanyu Zhang, Jessica Cedervall, Anahita Hamidi,

Cancer Research

2020

113

Elevated Expression of the C-Type Lectin CD93 in the Glioblastoma Vasculature Regulates Cytoskeletal Rearrangements That Enhance Vessel Function and Reduce Host Survival

Elise Langenkamp, Lei Zhang, Roberta Lugano,

Cancer Research

2015

92

Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment

Luuk van Hooren, Maria Georganaki, Hua Huang,

Oncotarget

2016

42

Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy

Maria Georganaki, Mohanraj Ramachandran, Sander Tuit,

OncoImmunology

2020

40

Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity

Kenney Roy Roodakker, Ali Alhuseinalkhudhur, Mohammed Al-Jaff,

European Journal of Nuclear Medicine and Molecular Imaging

2018

31

ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma

Hua Huang, Maria Georganaki, Lei Liu Conze,

Neuro-Oncology

2021

19

Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib

Marjut Niinivirta, Maria Georganaki, Gunilla Enblad,

BMC Cancer

2020

15

Page 1